The Biological Mass Spectrometry Centre (BMSC) is housed in UCL Great Ormond Street Institute of Child Health and headed by Dr Kevin Mills. The centre is primarily a research facility but we do offer basic service analyses. Please visit our proteomics and diagnostic services page for further information.
The BMSC has a history of developing specialised clinical assays which we have been providing for diagnostic services since 1984 with specialist analyses of urinary bile acids for inborn errors of metabolism. We were the first centre to develop and offer the assay for urine Gb3 which is a marker used in diagnosis and monitoring of Fabry disease. This assay is now used around the world in diagnostics and clinical trials and we are the main centre for Gb3 and lyso-Gb3 analyses in the UK through Great Ormond street hospital.
The Centre is focused on translational research and has capability and expertise in performing biomarker discovery and developing potential diagnostic molecules into, targeted translational tests that can be applied to clinical trials with NHS and industry. Our group works very closely with the BRC at Great Ormond Street Hospital and National Hospital for Neurology in both elucidating disease mechanisms involved in genetic metabolic disease and neurodegenerative conditions. It is a unique, state of the art environment where both clinical and non-clinical researcher’s work side by side using mass spectrometry based omics and targeted analyses.
Please contact us before applying for any grant to perform research in our centre as it needs to be fully costed beforehand. If you would like more information regarding what instrumentation we have then please follow the link to the technology section. If you would like to use mass spectrometry in your research then please spend 5 minutes reading the Frequently Asked Questions before contacting us.
BMSC logo kindly designed and provided by Adele Heywood